Veterinary Immunodiagnostics Market Forecast to Reach $2.71 Billion by 2029
Meticulous Researchu00aeu2014a leading global market research company, published a research report titled, nu2018Veterinary Immunodiagnostics Market by Product (Analyzers, Consumables {Leukemia, Influenza, BTV,n FMD, BTB, BHV}), Animal (Livestock, Companion), Technology (ELISA, Radioimmunoassay, Rapid Tests),n End User (Hospitals, Point of care)u2014Global Forecast to 2029.u2019
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Veterinary Immunodiagnostics Market Forecast to Reach $2.71 Billion by 2029
Veterinary Immunodiagnostics Market - 2023-2030 Meticulous Research a leading global market research company, published a research report titled, Veterinary Immunodiagnostics Market byProduct (Analyzers, Consumables {Leukemia, Influenza, BTV, FMD, BTB, BHV}), Animal (Livestock, Companion), Technology (ELISA, Radioimmunoassay, Rapid Tests), End User (Hospitals, Point of care) Global Forecast to 2029. Download Free Sample Report@ https://www.meticulousresearch.com/download-sample- report/cp_id=2897?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_co ntent=27-06-2024 In its latest publication, Meticulous Research reveals that the veterinary immunodiagnostics market is set to experience significant growth, with a projected Compound Annual Growth Rate (CAGR) of 9.3% from 2022, reaching an estimated value of $2.71 billion by 2029. This growth is driven by factors such as the rising prevalence of animal diseases, the availability of specialized immunodiagnostic tests, and significant technological advancements in immunodiagnostics. Additionally, the increasing pet population and demand for animal-derived products are further fueling market expansion. Emerging economies globally are expected to offer promising growth opportunities for the market, although the lack of adequate diagnostic infrastructure in developing nations remains a considerable challenge. The veterinary immunodiagnostics market is comprehensively segmented by Product (Analyzers and Consumables), Animal Type (Companion Animals and Livestock), Technology (ELISA, Radioimmunoassay, Rapid Tests, and Others), End User (Reference Laboratories, Veterinary Hospitals & Clinics, and Point of Care Testing), and Geography. This segmentation allows for a detailed analysis of industry competitors and market dynamics at regional and country levels. In 2022, the consumables segment is expected to dominate the market due to its high sensitivity, accuracy, rapid diagnosis, cost-effectiveness, and the availability of disease-specific immunoassays. Technologically, the ELISA segment is projected to hold the largest market share in 2022, driven by the ongoing development of novel biomarkers, cost-effectiveness, and the increasing adoption of automated ELISA platforms. The livestock segment is anticipated to capture the largest share of the market in 2022, fueled by the growing demand for food production and heightened awareness of animal health.The reference laboratories segment is forecasted to account for the largest share of the market in 2022, owing to the rising outsourcing of diagnostic testing by hospitals and clinics to reference laboratories. Geographically, North America is expected to lead the veterinary immunodiagnostics market in 2022, followed by Europe and Asia-Pacific. Factors such as increased awareness of animal health, well-established veterinary diagnostics infrastructure, and significant investments in pet health are expected to maintain North America's dominant market position. Key players in the market include IDEXX Laboratories, Inc. (U.S.), Zoetis Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Virbac (France), Heska Corporation (U.S.), Randox Laboratories, Ltd. (U.S.), Neogen Corporation (U.S.), QIAGEN N.V. (Germany), Abaxis, Inc. (U.S.), and bioM rieux S.A. (France). Page 1 of 2 Meticulous Research| sales@meticulousresearch.com
Veterinary Immunodiagnostics Market - 2023-2030 Buy Now@ https://www.meticulousresearch.com/Checkout/68519300?utm_source=pdf&utm_medium=soc ial&utm_campaign=product&utm_content=27-06-2024 About Meticulous Research : Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 2 of 2 Meticulous Research| sales@meticulousresearch.com